Roffman Miller Associates Inc. PA Has $2.28 Million Stock Position in Colgate-Palmolive Company (NYSE:CL)

Roffman Miller Associates Inc. PA increased its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 31.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,359 shares of the company's stock after purchasing an additional 5,845 shares during the quarter. Roffman Miller Associates Inc. PA's holdings in Colgate-Palmolive were worth $2,282,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Westend Capital Management LLC increased its position in Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 140 shares during the period. Vermillion Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $31,000. Briaud Financial Planning Inc acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $32,000. Wintrust Investments LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $33,000. Finally, Accredited Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $34,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.7%

Shares of Colgate-Palmolive stock opened at $91.75 on Monday. Colgate-Palmolive Company has a 12-month low of $85.32 and a 12-month high of $109.30. The business's 50 day moving average is $90.61 and its 200-day moving average is $90.52. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The stock has a market cap of $74.36 billion, a P/E ratio of 25.92, a P/E/G ratio of 4.93 and a beta of 0.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter in the prior year, the business earned $0.86 EPS. The firm's revenue for the quarter was down 3.0% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has authorized a share repurchase plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 6.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's management believes its shares are undervalued.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend is Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CL shares. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Piper Sandler decreased their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Barclays decreased their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, April 11th. Finally, Citigroup boosted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $101.69.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.